SLC5A2 and hydrops fetalis: However, the specific impact of SGLT2 inhibitors on patients with HF subsequent to AMI—a period marked by intense hemodynamic, metabolic, and inflammatory stressors—remains a field worthy of focused research (Hoehlschen et al., 2023).